Aslan, Thermo Fisher team up to make eblasakimab for clinical trials

Aslan, Thermo Fisher team up to make eblasakimab for clinical trials

Source: 
MSN/Seeking Alpha
snippet: 

Aslan Pharmaceuticals (NASDAQ:ASLN) said it is collaborating with Thermo Fisher Scientific (NYSE:TMO) to manufacture a high concentration formulation of eblasakimab for phase 3 trials.